BRII-198

· Brii Biosciences Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BRII-198, covering 2023-03-03 to 2023-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 [Phase 2]